KORU Medical Systems, Inc.
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 and FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
Market Cap
$104.8M
Volume
110.9K
Cash and Equivalents
$9.6M
EBITDA
-$5.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$21.3M
Profit Margin
63.40%
52 Week High
$5.05
52 Week Low
$2.05
Dividend
N/A
Price / Book Value
6.23
Price / Earnings
-17.21
Price / Tangible Book Value
6.51
Enterprise Value
$99.2M
Enterprise Value / EBITDA
-19.15
Operating Income
-$6.4M
Return on Equity
32.64%
Return on Assets
-14.47
Cash and Short Term Investments
$9.6M
Debt
$4.0M
Equity
$16.8M
Revenue
$33.6M
Unlevered FCF
$116.9K
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium